Yuzo Watanabe

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Vitamin D receptor activators (VDRA) may exert pleiotropic effects on cardiovascular disease, malignancy, and infections among dialysis patients, but recent studies have mainly focused on cardiovascular outcomes. Among 8,675 patients who started dialysis in 2007 and who survived until January 1, 2010, listed in the Renal Data Registry of the Japanese(More)
BACKGROUND There is limited data showing that early treatment for anemia could prolong renal survival in non-dialysis chronic kidney disease (CKD) patients. We therefore investigated the relationship between hemoglobin (Hb) levels at initiation of epoetin beta therapy and renal outcome in non-dialysis CKD patients with anemia. METHODS In this prospective,(More)
may have a beneficial effect in preventing Epo-induced hypertension; however, they must never be instituted when hypertension has already developed. In this case, I recommend , as Dr Dorhout Mees does, to check and try to reduce blood volume as the first step for controlling blood pressure increases. changes induced by the correction of anaemia by(More)
  • 1